APPLICATION
ANDA212174
TYPE
ANDA
ORIGINAL APPROVAL
2019-05-03
LATEST ACTION
2025-05-08
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
FUROSEMIDEPrescription
FUROSEMIDE 10MG/ML · INJECTABLE · INJECTION
Approval history
2025-05-08Labeling · Supplement 2 · standardAP
2019-05-03UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.